39m
Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted ...
According to DataM Intelligence. The Prescription Drugs Market Size, valued at a substantial US$1240.33 billion in 2024, is ...
Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.
Fresenius Kabi has launched its denosumab biosimilars Conexxence® and Bomyntra® across Europe following European Commission approval in July 2025 for all indications of their reference medicines ...
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional ...
Disease development is often shaped by genetics, with how much or how little a gene is expressed influencing disease risk.
Pharmaceutical Technology on MSN
Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved
A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.
New research analyzing 2,693 dog genomes reveals most modern dogs carry wolf DNA from ancient hybridization. Discover how wolf genes helped dogs survive and what this means for breeds from Chihuahuas ...
A new multilateral treaty which India is preparing to sign poses a catastrophic threat to 150 million Indian farmers ...
Tech-savvy parents to be are using IVF and screening embryos to build families in ways that were unimaginable a few short years ago.
After releasing two gene-edited rice varieties in May this year, scientists are now focusing on developing GE varieties of ...
Key breakthrough for the return of the dodo: viable cells have been obtained and genetically modified birds have been prepared.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback